HIT Consultant

JULY 26, 2022

Since the release of the Health app in 2014 and Apple Watch in 2015, Apple has introduced a wide array of innovative health and fitness features, with the goal to provide users with easy-to-understand, meaningful insights so they can be empowered to live a healthier life. Empowering Users on Their Personal Health Journeys.

Public Health 98

Public Health COVID-19 Governance World Health 98

Healthcare IT Today

DECEMBER 26, 2022

Nectar is the consumer-facing brand of Nectar Life Sciences , an allergy-focused healthcare holding company led by Dr. Chahine, one of the country’s leading entrepreneurial operators at the intersection of science and healthcare. About Nectar Life Sciences. ” Learn more at mynectar.com.

60

60

Healthcare It News

JANUARY 24, 2022

Kleinz, senior vice president and head of translational sciences at UPMC Enterprises, the innovation, commercialization and venture capital arm of UPMC. "Our efforts are led by the Institute for Precision Medicine, which was established in 2014 in collaboration with our academic research partner, the University of Pittsburgh."

Hospitals 270

Hospitals Governance COVID-19 Nurses 270

SQA

DECEMBER 16, 2022

The 20-page Q&A document covers general and specific topics including the importation of cannabis products, simplified authorization procedures for education, and research institutions that are conducting cannabis studies using real-life data. 26 of 2014. CMDE Announcement No. 04 Orthopedic Surgical Instruments.

FDA 40

FDA Compliance COVID-19 Licensing 40

HIPAA Journal

DECEMBER 24, 2022

The four categories used for the penalty structure are as follows: Tier 1: A violation that the covered entity was unaware of and could not have realistically avoided, had a reasonable amount of care had been taken to abide by HIPAA Rules. Each category of violation carries a separate HIPAA penalty. HIPAA Violation Penalty Structure.

HIPAA 122

HIPAA Compliance Hospitals COVID-19 122

Health Law Advisor

AUGUST 10, 2023

Medical Device Data Systems Prior to FDA’s Mobile Medical App Guidance, this topic was addressed by FDA when it created the category of Medical Device Data Systems (“MDDS”). FDA took the position that such reprocessing was a manufacturing operation because it extended the life of what was otherwise a single use medical device.

FDA 98

FDA Licensing Hospitals Medicaid 98

SQA

FEBRUARY 26, 2024

The products had been improperly regularized in ANVISA as cosmetics since they are indicated for injectable use, a form that is not authorized for this category of product. The purpose of the note is to clarify that products for invasive aesthetic treatments cannot be regularized in the category of cosmetics.

FDA 52

FDA Compliance COVID-19 Public Health 52